Additrace N®

(chromium, copper, iron, manganese, iodine, fluoride, molybdenum, selenium, zinc)

For Republic of Ireland healthcare professionals only. This content contains promotional and brand information.
 
Additrace N® prescribing information is available by clicking on the link below.

Trace element solution for intravenous nutrition in adults, and children weighing ≥40kg body weight.

PN should be monitored, and doses adjusted according to individual patient response. Please refer to the Summary of Product Characteristics before prescribing.

Please note product image is for illustrative purposes only and labelling on actual product may appear differently.

Filename
Additrace N® Prescribing Information 1.pdf
Size
496 KB
Format
pdf
Additrace N® Prescribing Information

Details

Contains trace element levels aligned with the suggested daily parenteral intakes in adults in the European Society for Clinical Nutrition and Metabolism (ESPEN) 2022 guidelines for micronutrient provision.1*

1. Berger MM, Shenkin A, Schweinlin A, Amrein K, Augsburger M, Biesalski H-K, et al. ESPEN micronutrient guideline. Clin Nutr [Internet]. 2022;41(6):1357–424. Available from: https://www.espen.org/files/ESPEN-Guidelines/ESPEN_micronutrient_guideline.pdf

*The PN patient population is heterogeneous and fixed micronutrient doses may not be appropriate for all individuals.

Extensive compatibility and stability information with PN regimens is available from our medical information team: Medical.Information-UK@fresenius-kabi.com

To meet basal to moderately increased requirements of trace elements in intravenous nutrition. For use in adults, and children ≥ 40kg body weight.

Item description Unit sizeCase qty Item code 
Additrace N10ml ampoule20FIA1921

 Per 10ml ampoule:Corresponds to:

Chromic chloride hexahydrate

53.3 microgramCr 0.2 µmol /10 µg
Copper chloride dihydrate1.02 milligramCu 6 µmol / 380 µg
Ferric chloride hexahydrate5.40 milligram Fe 20 µmol / 1.1 mg
Manganese chloride tetrahydrate198 microgramMn 1 µmol / 55 µg
Potassium iodide166 microgram I 1 µmol / 130 µg
Sodium fluoride2.10 milligram F 50 µmol / 950 µg
Sodium molybdate dihydrate48.5 microgramMo 0.2 µmol / 19 µg 
Sodium selenite173 microgramSe 1 µmol / 79 µg 
Zinc chloride10.5 milligramZn 77 µmol / 5 mg
Adverse events should be reported.
Reporting forms and information can be found at:
www.hpra.ie/homepage/about-us/report-an-issue
Adverse events should also be reported to Fresenius Kabi Limited, Cestrian Court, Eastgate Way, Manor Park, Runcorn, Cheshire, WA7 1NT Tel +44 (0)1928 533 533.

Job code: IE-Adce-2400001

Date of preparation: November 2024